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Abstract
Thyroid hormones are important regulators of
lipid metabolism. Polymorphonuclear leukocytes
(PMN) are essential components of innate immune
response. Our goal was to determine whether
hypothyroidism affects lipid metabolism in PMN
cells. Wistar rats were made hypothyroid by
administrating 0.1 g/L 6-propyl-2-thiouracil (PTU)
in drinking water during 30 days. Triacylglycerides
(TG), cholesterol and phospholipids were determined
in PMN and serum by conventional methods. The
mRNA expression of LDL receptor (LDL-R), 3-
hydroxy-3-methylglutaryl-CoA reductase (HMGCoAR),
sterol regulatory element binding protein 2 (SREBP-
2), and diacylglycerol acyltransferase 2 (DGAT-2)
were quantified by Real-Time PCR. Cellular neutral
lipids were identified by Nile red staining. We
found hypothyroidism decreases serum TG whereas
it increases them in PMN. This result agrees with
those observed in Nile red preparations, however
DAGT-2 expression was not modified. Cholesterol
synthesizing enzyme HMGCoAR mRNA and
protein was reduced in PMN of hypothyroid rats. As
expected, cholesterol content decreased in the
cells although it increased in serum. Hypothyroidism
also reduced relative contents of palmitic, stearic, and
arachidonic acids, whereas increased the myristic,
linoleic acids, and the unsaturation index in PMN.
Thus, hypothyroidism modifies PMN lipid composition.
These findings would emphasize the importance
of new research to elucidate lipid-induced alterations
in specific function(s) of PMN.
Introduction
Hypothyroidism is one of the most-frequently-ob-
served pathological conditions in the general
population, its incidence being higher in women than in
men [1].
It is well known that thyroid dysfunction leads to
changes in lipoprotein metabolism [2]. Low-density lipo-
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protein cholesterol (LDL-C) and high-density lipoprotein
cholesterol (HDL-C) levels increase in the plasma of
hypothyroid patients. On the contrary, LDL-C and HDL-
C decrease in hyperthyroidism. Furthermore, clearance
of chylomicron remnants is reduced in hypothyroidism
[3].
Induction of hypothyroidism in rats increases con-
centrations of total cholesterol (TC) in serum and cho-
lesterol in low-density lipoproteins (LDL) [4]. Choles-
terol content changes in high density lipoproteins (HDL)
by the hypothyroidism are a controversial question that
remains to be addressed. Some authors have reported
that HDL-C levels increased [5], other authors did not
find changes in HDL-C levels [6], while others found
diminished HDL-C concentrations [7]. The TG concen-
tration decreased in the serum of hypothyroid rats [2, 7,
8].
In addition, it has been demonstrated that hypothy-
roid condition decreased the mRNA levels of apoA-I and
apoA-IV in rat liver suggesting that thyroid hormones
may play an important role in regulating the mRNA lev-
els of specific apolipoproteins [9].
So far, it is known that the immune system protects
host from environmental infectious agents, such as patho-
genic bacteria, viruses, fungi, parasites and other noxious
insults. Innate immunity is the first line of defence against
infectious agents and it consists of physical barriers (e.g.
skin), soluble factors (e.g. complement) and phagocytic
cells like neutrophils, monocytes and macrophages [10].
Neutrophils are released into the bloodstream -where they
circulate- and die by apoptosis after a half-life of approx.
7 hours. They can also respond to signals of localized
infection, migrate through the vascular endothelial walls
into tight tissue spaces seeking out the infectious agents
for phagocytosis and destruction [11, 12]. The lipid com-
position is very important in phagocytes for their protec-
tive functions. It has been demonstrated that changes in
the membrane lipid composition of macrophages alter the
clearance of apoptotic cells by regulating their phago-
cytic rate through phosphatidylinositol 3-kinase signaling
[13].
There is a connection between immune function and
lipid metabolism. It is well known that cholesterol plays a
key role in membrane structure, and that it is a major
player in the lipid rafts which have a vital role in cell
signalling and protein sorting on the membrane surface
[14]. Moreover, the expression of functional LDL-R was
assessed by flow cytometry in PMN, monocytes and
lymphocytes by Lara and coworkers [15]. These authors
found that LDL-R expression and avidity are higher in
PMN compared with mononuclear cells. Bonneau et al.
[16] showed that low-density lipoproteins increase
the production of superoxide anion and inhibit the chemo-
tactic response of PMN to C5a and formyl-methionyl-
leucyl-phenylalanine. These observations would indicate
that PMN’s functions could be altered by the environ-
mental conditions in which they are embedded, including
the presence of lipoproteins. In the same way, changes
in membrane cholesterol and/or phospholipids fatty acid
composition might be expected to influence immune cell
function in a variety of ways. For instance, in vitro stud-
ies have clearly demonstrated that alterations in phago-
cyte membrane fatty acid composition are associated with
altered phagocytic capacity, T-cell signaling and antigen
presentation capability. These effects appear to be medi-
ated at the membrane level, suggesting fatty acids play
important roles in membrane arrange, lipid raft structure
and function, and membrane trafficking [10].
To our knowledge, this is the first work that studies
the influence of a frequent disease, such as hypothy-
roidism, not only on the fatty acid, but also on the TG,
phospholipids and cholesterol contents of PMN cells, key
effectors of the innate immune response. Thus, taking
into account above observations and considering that PTU
has been used in experimental models to cause hypothy-
roidism [4, 9], we were aimed to investigate (i) the ex-
pression of mRNAs of key factors involved in lipid me-
tabolism and (ii) the fatty acyl composition of total lipids
from PMN cells from PTU-induced hypothyroid rats.
Results from these studies could contribute to the under-
standing of the relationship between lipid metabolism and
PMN functions.
Materials and Methods
Chemicals
Lipid standards were acquired from Sigma Chemical
Co. (St. Louis, MO). All other chemicals were of analytical
grade and obtained from Merck Laboratory (Darmstadt, Ger-
many).
Experimental model
Adult female Wistar rats bred in our animal facility (patho-
gen-free certified) were used throughout the experiments. Ani-
mal body weights were 175 ± 25 g at the onset of
the treatment. The rats were kept in a light and
temperature–controlled room with lights on between 06.00–
20.00 h and temperature between 22–24 ºC. Rat chow (Cargill,
Córdoba, Argentina) and tap water with or without PTU sup-
plementation (0.1 g/L) were available ad libitum. PTU daily
intake was 2.61± 0.08 mg/día/rat. After a 30-days treatment,
Cell Physiol Biochem 2012;29:713-724
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euthyroid (ET) and hypothyroid (HT) rats were killed by de-
capitation between 09.00–10.00 a.m. All procedures were con-
ducted in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals (NIH Publi-
cations No. 80-23). Experimental protocols were reviewed and
approved by the National University of San Luis Committee’s
Guidelines for the Care and Use of Experimental Animals.
Thyroid profile
The thyroid profile was assessed by chemiluminescence’s
assays. Free T4 (FT4) and TSH were determined by
using a commercial kit for the autoanalyzer ACS: 180 PLUS
(Ciba Corning, Bayer Health Care, MA, USA) in the Labora-
tory of Clinical Analysis at the San Luis Hospital. The intra-
assay coefficient of variation was 1.54 % for estimation of FT4
at 1.42 ng/dL and 3.01 % for TSH at 18.53 µIU/mL. The ACS:180
TSH assay is a two-site immunoassay, and even though
not specific for rat; it has been previously validated in our
laboratory with satisfactory and reproducible results. The
cross-reactivity of either FSH or LH in this assay was less than
6%.
Haematological parameters
Whole blood samples were analysed for white blood cells
(WBC), red blood cells (RBC) and platelets (PLT) counts using
the automated haematological analyser, Cell Dyn 1200 (Abbott
Laboratories, Philippines).Smears preparations were stained by
May Grünwald–Giemsa [17], and leukocytes subsets were iden-
tified by light microscopy and counted by the same operator.
Isolation of polymorphonuclear leukocytes
PMN leukocytes were isolated by density-gradient cen-
trifugation with Ficoll-Histopaque 1083 solution [18]. Blood
was drawn into a tube containing EDTA and sedimented on
3 % dextran for 30 min. Supernatant was recovered and
spooned at 240 x g for 10 min. The pellet of PMN cells was
resuspended in 8 ml of sterile saline (PBS, pH 7.40) buffer, lay-
ered onto 4 ml Ficoll-Histopaque solution and centrifuged at
400 x g for 40 min at 20 ºC. Contaminating erythrocytes
were eliminated by 30 sec hypotonic lysis in sterile distilled
water with the addition of 1.6 % NaCl for maintaining
low osmolarity. Purified cells were finally resuspended in Hanks’
balanced salt solution (HBSS, pH 7.40) without Ca²+ and Mg²+.
Cell purity was >98% and cell viability >96% as assessed by
the trypan blue dye exclusion test [19].
Lipid analysis
Blood samples were centrifuged at 400 x g for 10 min at
25 ºC within 1 h of sampling, and serum was separated and kept
at 4 ºC until were analyzed. TG, total cholesterol (TC), and
HDL-C measurements were performed within 4 h of samples
isolation. Serum lipid concentrations from ET or HT rats
were determined in fresh serum samples. HDL-C was measured
in the supernatant after precipitation of other lipoproteins by
the dextran sulfate-MgCl2 procedure [20]. LDL-C was
calculated by means of the Friedewald formula [21]. TG, TC
and HDL-C were measured by enzymatic methods (kits from
Wiener Lab, Rosario, Argentina) using a Metrolab 2300
autoanalyzer. For calibration purpose a standard (reference)
lyophilized serum from Wiener Lab was used. Total lipids
were extracted from PMN leukocytes using chloroform-metha-
nol (2:1; chromatographic purity) according to the
method described in Folch et al. [22]. Lipid extracts were dis-
solved in n-hexane and the different lipids were separated by
thin-layer chromatography with an N -hexane-diethyl ether-
acetic acid (80:20:1; v/v/v) as solvent system [23]. Complex
lipids were localized using iodine vapour, identified by means
of their Rf values and scrapped-off the plates. Phospholipids
were determined according to Fisk et al. [24] while free (FC)
and esterified (EC) cholesterol were determined following
the method described in Zack et al. [25] after saponification
[26]. TG content was quantified by the method of Sardesai and
Manning [27].
Fatty acid analysis
The fatty acyl composition of complex lipids in PMNs
was determined by capillary gas-liquid chromatography
(c-GLC). In brief, PBS washed cell suspensions (containing 1 x
106 PMNs) were treated as indicated below to obtain total
lipid extracts. After dried under nitrogen at (2 ºC), the extracts
were saponified and processed to obtain the fatty-acyl methyl
esthers (FAMEs) as indicated in a previous paper [28], except
that in this case we used a capillary column mounted on a
Hewlett Packard HP 6890 Series GC System Plus (Avondale,
PA) equipped with a terminal computer integrator and a data
station A-680 Plus. Before injection into the c-GLC system, the
FAMEs were purified by HPTLC chromatography using silica
gel glass plates from Merck (Darmstadt, Germany) with zone
concentration bands. The solvent system was previously
detailed [23]. Chromatographic patterns of the FAMEs were
identified by comparison of their relative retention times with
authentic standards (Sigma Chem. Co, St. Louis, MO)
running in parallel with each set of samples. Relative mass
distribution of each analysis was calculated electronically by
quantification of each fatty acid peak area divided by the
sum of all areas.
Neutral lipid accumulation in PMN cells by Nile red
staining test
The lipid content in isolated PMN cells was
fluorometrically determined using Nile red, a vital lipophilic
dye for labeling neutral lipid accumulation in cytosol. Stock
solution of Nile red (1000 µg/mL) in acetone was prepared and
stored protected from light. Isolated PMNs (1-2 x 106/mL) were
resuspended in PBS, smeared on delipidated cover slips and
fixed with 2 % paraformaldehyde for 15 min. Leukocyte smears
were incubated for 10 min with Nile red solution at a final
concentration of 2.5 µM in PBS at 25 °C. Cellular preparations
were washed with PBS and counted, by the same operator, in
an epifluorescence microscope Nikon Eclipse E50i (Nikon
Corporation, Tokyo, Japan) with excitation to 494 nm and
emission 521 nm. A total of 400 cells of each group were counted
with a 1000X magnification.
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Total RNA preparation
PMN cells isolated from 10 mL of whole blood
were resuspended in 300 µL HBSS and homogenized in 700 µL
TRIzol reagent solution (Invitrogen, USA). Total RNA was ex-
tracted following the manufacturer’s suggested protocol, ex-
cept that the isopropanol precipitation step was performed
overnight at -20 ºC. Purified total RNAs were then quantified
and assessed for purity by measurement of the ratio 260/280
nm optical density using an UV spectrophotometer Beckman
DU-640 B (CA, USA).
Reverse transcription reaction
cDNA was synthesized using the Moloney Murine
Leukemia Virus Reverse Transcriptase (MMLV-RT) and ran-
dom primer hexamers. A reaction mixture (15 µL) containing 200
ng of total RNA, 100 pmol of random primer hexamers and
RNAse-free water was pre-heated at 70 °C for 5 min. Reverse
transcription reaction was allowed to occur at 37 °C for 1 h after
adding 5 µL of 5X reaction buffer, 20 µmol dNTPs and 200 IU of
MMLV-RT in a final incubation volume of 26 µL. The mixture
was then heated at 75 °C for 15 min in order to inactivate the
MMLV-RT. The cDNA solution was then stored at –20 °C until
use. Fragments coding for LDL-R, HMGCoAR, SREBP-2, DGAT-
2 and β-actin (as endogenous control) were amplified and quan-
tified by Real Time-PCR using specific primers. These were
designed using the Primer Express 3.0 software. The forward
(FW) and reverse (RV) primer sequences used for each gene
are listed in Table 1.
Relative quantification of mRNA LDL receptor, HMGCoA
reductase, SREBP-2 and DGAT-2 expression
The mRNA expression levels of LDL-R, HMGCoAR,
SREBP-2 and DGAT-2 were quantified using real-time quanti-
tative PCR. Twenty µL of the reaction mixture contained 12.5
µL of SYBR Green PCR master mix (Applied Biosystems, Chesh-
ire, U.K.), 200 nM of each primer, 5.5 µL of water and 5 µL of
cDNA. The thermalcycling conditions were: 10 min at 95 ºC
followed by 40 cycles of 15 sec at 95 ºC - 1 min at 60 ºC and a
final dissociation step (at 95 °C for 15 sec, 60 °C for 30 sec, and
95 °C for 15 sec) in an ABI PRISM 7500 real-time PCR system
(Applied Biosystems). β-Actin mRNA levels were determined
as endogenous control. No-template control tubes (NTC) -con-
taining water instead of template mRNA- were run under the
same reaction and thermalcycling conditions for each pair of
primers. Samples were processed in triplicates and the experi-
ment was repeated at least twice. The specificity of the amplifi-
cation reaction was confirmed by examining the dissociation
curve. Data were obtained with the 7500 System SDS version
1.3 software (Applied Biosystems) and were expressed as Ct
(cycle threshold), ΔCt (target Ct - β-Actin Ct), and RQ (relative
quantification). The background fluorescence was removed
by resetting the noise band. The relation between the Ct and
the initial amount of cDNA was found to be linear. The correla-
tion coefficient (r) was near to 1, and PCR amplification
efficiencies of the target genes and the endogenous control
were similar and close to 100%. Real-time PCR efficiencies were
calculated from the slopes of the standard curves according to
the equation E = 10(-1/slope). RQ values were obtained using
the 2-ΔΔCT method, adjusting the target mRNA to the β-actin
mRNA expression and considering the target/β-actin normal-
ized expression in rat liver as reference RQ = 1. RQ values were
expressed as mean ± standard deviation and were statistically
analysed using the Graph Pad Prism 4.0 software.
HMGCoA reductase analysis by Western Blotting
After washing the PMNs suspensions with HBSS (cen-
trifuging twice at 240 x g for 1 min with 500 µl each), cell
homogenates were prepared in lysis buffer (50 mM Tris-HCl,
pH 7,4 with 1 X proteases inhibitors) and centrifuged at 10300
x g for 30 min. Protein concentration in the supernatant was
measured using the Lowry method. Five microliters of sample
buffer (250 mM Tris, 4% β-mercaptoethanol, 4% SDS, 40% glyc-
erol, and 0.002% bromophenol blue) were added to all samples
(40 ug of protein in each) and each mix was taken to a final
volume of 20 ul with distilled water. The samples were then
boiled for 5 min, and applied to 10% polyacrylamide gels.
Pre-stained molecular weight markers of 4 to 250 kDa were
applied to one lane (SeeBlue Plus 2 Prestained; Invitrogen/Life
Technologies). The electrophoretically separated proteins were
transferred to a PDVF Immobilon-P (Millipore Corporation)
membrane. Each membrane was blocked with 5% nonfat dry
milk and incubated at room temperature for 1 h with a 1:500
dilution of a rabbit polyclonal antiserum against rat HMGCoAR
protein (H-300, Santa Cruz Biotechnology) followed by a sec-
ondary antibody conjugated to horseradish peroxidase
(Thermo Scientific Pierce Antibodies). Images were acquired
Table 1. Primers sequence used in Real Time PCR
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Table 2. Effects of PTU treatment on serum concentrations of free T4, TSH,
triacylglycerides, total cholesterol, HDL-cholesterol and LDL-cholesterol in rats.
Values are means ± SEM for groups of eight rats. a P < 0.05 compared with the
respective control groups using t-test.
Table 3. Effects of PTU treatment on concentrations of phospholipids, free choles-
terol, esterified cholesterol and triacylglycerides in polymorphonuclear leukocytes
of rats. Values are means ± SEM; n, number of rats. a P < 0.05 compared with the
respective control groups using t-test.
Table 4. Effects of hypothyroidism on the relative fatty acyl composition of total
lipids from polymorphonuclear leukocytes of rats. Values are means ± SEM of spe-
cific fatty acids percents. Relative mass distribution of each analysis was calculated
electronically by quantification of each fatty acid peak area divided by the sum oh all
areas. Analyses were performed by capillary gas-liquid chromatography using three
pools (n = 3) of blood samples from either eight ET or eight PTU-treated (n = 3) rats.
a P < 0.01 and b P < 0.001 compared with the control groups using t-test.
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after enhanced chemiluminescence (ECL) using a FluorChem
HD2 imager from AlfaInnotech (San Leandro, CA). The
mean of intensity of each band was measured using the NIH
ImageJ software (Image Processing and Analysis in Java
from http://rsb.info.nih.gov/ij/). The HMGCoA-R protein
levels were normalized against ACTIN (endogenous
control).
Statistical analysis
Statistical analysis was performed using the unpaired
Student’s t-test. When variances were not homogeneous, we
Fig. 1. Representative photomicrographs of Nile red stained
lipid droplets of PMNs pools from euthyroid (A and B, n = 4)
and hypothyroid (C and D, n = 4) rats. The neutral lipid
accumulation was more frequent and pronounced in PMNs
from hypothyroid rats (33.0 ± 5.0 % PMNs exhibited abundant
lipid droplets in HT rats, while this percentage was only 7.1±
1.1 % in ET animals) as detected by neutral lipid staining. PMNs
were treated with Nile red and observed with fluorescence
microscopy. A total of 400 cells of each group were counted.
Arrows indicate PMNs with abundant lipid droplets. Original
magnification, 1000X.
Fig. 2. Relative quantifications of LDL-R, HMGCoAR, SREBP-
2 and DGAT-2 mRNA expressions in PMN leukocytes from ET
and HT rats. The corresponding mRNA expression level in rat
liver was used as calibrator. The quantification was done by
Real Time-PCR using four pools of eight ET and PTU-treated
rats, respectively. The determination was done in triplicate. No
significant differences were observed between ET (left bar)
and HT rats (right bar) in the LDL-R, SREBP-2 and DGAT-2
level mRNA expressions. The HMGCoAR level mRNA
expression was markedly diminished in the HT group. * P <0.05
compared with the respective control groups using t-test.
performed unpaired t-test with Welch’s correction. A statistical
significance was considered valid when P < 0.05.
Results
Serum levels of thyroid hormones and TSH
We found the FT4 levels decreased, and that TSH
concentration increased in the serum of PTU-treated (HT)
rats as compared to the ET group (Table 2).
Effect of hypothyroidism on haematological
parameters
Since it is known that hyperthyroidism treatment with
PTU is associated with agranulocytosis and leukopenia
[29, 30], we measured haematological parameters in our
experimental model.
Experimental hypothyroidism did not affect the
counts of WBC (ET: 5,80 x 103/mm3 ± 0,76 vs HT: 9,99
x 103/mm3 ± 1,73), RBC ( ET: 5,11 x106/mm3 ± 0,11 vs
HT: 5,95 x106/mm3 ± 0,41) and PLT (ET: 568,80 x 103/
mm3 ± 47,70 vs HT: 374,50 x 103/mm3 ± 108,40). In our
model of hypothyroidism the PMN percentage was not
statistically distinguishable from control data (ET: 40,83
% ± 4,77 vs HT: 43,43 % ± 2,82).
Cell Physiol Biochem 2012;29:713-724
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Effect of hypothyroidism on serum lipids
Since it is well known that thyroid dysfunction leads
to changes in lipoprotein metabolism, we measured the
concentrations of TG, TC, HDL-C and LDL-C in
the serum of HT and ET rats. Circulating TG
concentration was diminished in HT rats; however, TC
and LDL-C were markedly elevated. The PTU treatment
had no significant effect on circulating HDL-C levels
(Table 2).
Effect of hypothyroidism on lipid levels in PMN
leukocytes
Changes in the serum lipid profile observed in
the HT group might influence the lipid composition in
different cells and tissues, including those involved in
the immune function. This led us to measure the
phospholipids, FC, EC and TG contents in PMN
leukocytes (Table 3). Hypothyroidism did not alter the
phospholipids concentration in PMN cells; however, it
modified the cholesterol levels. EC and FC concentrations
decreased in the PMNs of HT rats. On other hand, the
TG levels increased in the PMNs of HT animals in
comparison to ET rats.
Effect of hypothyroidism on PMN leukocytes
fatty acid composition
The experimental hypothyroidism also affected the
relative contents of fatty acyl chains from complex lipids
in PMNs cells. We observed a decreased amount of
palmitic, stearic, and arachidonic acids but an increased
content of myristic and linoleic acids in complex lipids in
HT PMN cells. In agreement with these changes, the
unsaturation index increased in the HT group as compared
to ET group (Table 4).
Effect of hypothyroidism on neutral lipid
accumulation in PMN cells
Lipid droplets or lipid bodies (LBs) are spherical,
non–membrane-bound lipid-rich cytoplasmic
inclusions found inside various inflammatory cells.
The LBs in neutrophils are largely composed of TG.
We found increased TG levels in PMNs. Then, we decided
to investigate the LBs contents in PMN. Hypothyroidism
increased the LBs accumulation in PMNs as
observed by the Nile red staining. In HT rats almost
33.0 ± 5.0 % of the PMNs exhibited abundant LBs,
while this percentage was only 7.1 ± 1.1 % in ET
 animals (Fig. 1).
Effect of PTU treatment on levels of LDL-R,
HMGCoAR, SREBP-2 and DGAT-2 mRNA
expression in PMN leukocytes
To elucidate the causes of the decreased
cholesterol content in leukocytes, we determined the
expression levels of LDL-R, involved in cholesterol
uptake, and HMGCoAR, the rate-limiting enzyme of
Fig. 3. Hypothyroidism modifies the HMGCoAR protein levels in PMN leukocytes. A- Western Blotting analysis of HMGCoAR
and ACTIN of PMN leukocytes from euthyroid and hypothyroid rats. The major HMGCoAR band is at 80-97kDa. The lower
bands are proteolytic products resulting from sample processing. Samples of PMN homogenates, 40 µg, from euthyroid (1,2,3,4)
and hypothyroid (5,6,7,8) rats were applied. B – Levels of HMGCoAR protein corrected against ACTIN as endogenous control.
Bars represents means ± SD (n=4). * indicates significant difference (p = 0.0078) using unpaired t test.
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cholesterol biosynthesis. Experimental hypothyroidism
did not affect the mRNA levels of LDL-R in PMNs but
it diminished significantly the HMGCoAR mRNA
expression (Fig. 2).
SREBP-2 is a transcriptional factor that activates
not only the LDL-R transcription but also other
genes directly involved in cholesterol homeostasis.
Thereafter, we quantified SREBP-2 expression in
the PMNs of HT and ET rats. We found no significant
differences between groups (Fig. 2).
The increase in the TG content observed in
PMNs of HT rats could be due to an increase in de
novo TG biosynthesis. DGAT-2 catalyzes the terminal
and only committed step in the cellular TG synthesis.
Thus, we decided to quantify the DGAT-2 mRNA levels
in the PMN cells of HT rats. Results demonstrated
there were no significant changes between groups
(Fig. 2).
Effect of PTU treatment on protein level of
HMGCoAR in PMN cells
Taking into account that HMGCoAR mRNA content
was significantly diminished in the PMN cells of HT rats,
we measured the HMGCoAR protein levels.
Consistently with above results, levels of
HMGCoAR protein decreased in the PMNs of HT in
comparison to ET animals (Fig. 3).
Discussion
Thyroid status has a great influence on serum
lipid levels, and it is also very important for the lipid
content of cells [31, 32]. Maintenance of the physiological
lipid composition in the phagocyte cells is essential for
proper biomembrane structure and function, and for
the normal functional performance of this type of
immune cells [33, 34]. Here, we studied the effects of
hypothyroidism on lipid levels and on lipid metabolizing
enzymes expression in the PMN cells. As expected, our
hypothyroid animal model was characterized by reduced
FT4 and increased TSH serum levels (Table 2). These
results are consistent with the FT4 and TSH levels
observed by other authors [4, 35, 36] in a similar animal
model.
Regarding circulating lipid levels, our results
(Table 2) are consistent with others’ previous
findings which also showed changes in serum lipid
composition hallmarked by increased TC and
LDL-C contents in HT individuals [3, 34, 37]. However,
the HDL-C was not altered in our experimental
model. Hypothyroidism also provoked a significant
decrease of the serum TG concentration. The inverse
correlation between serum TC and thyroid hormone
levels has been known from experimental observations
which date back to over 70 years [38]. Hypothyroidism-
associated hypercholesterolemia would mainly be due
to a decreased rate of receptor-mediated catabolism of
the plasmatic lipoproteins in the liver. On the other
hand, the decrease in the TG levels has been
attributed to an overall increase in the peripheral lipoprotein
lipase activity [39].
In this study, we also found hypothyroidism
caused a significant decrease of FC and EC in the PMN
cells (Table 3). Results strongly suggest that
these alterations were likely due to a decrease in the
mRNA and protein levels of HMGCoAR, the key
enzyme for cholesterol biosynthesis. Previous studies [40]
showed that hypothyroidism causes a decrease in the
mRNA, protein and activity levels of HMGCoAR in the
rat liver. These effects were reverted by a T3
treatment [40]. On the contrary, Cachefo and
collaborators [41] found an increased HMGCoAR
mRNA expression in mononuclear leukocytes
from hyperthyroid patients; however, they
did not find significant changes in LDL-R expression
[41]. We did not find significant changes in LDL-R
expression in PMNs of our hypothyroid rats, either. Thus,
the mRNA expression of LDL-R may not be regulated
by the thyroid hormone, at least in this type of
immune  cells. Moreover, other experimental data
suggest that cholesterol synthesis and LDL-R-mediated
cholesterol uptake may work independently, and
that receptor-mediated LDL uptake is a secondary
compensatory mechanism following cholesterol
synthesis [14]. However, other authors found
that HMGCoAR as well as LDL-R mRNA, protein
levels and activity, were all increased in the liver of
rats treated with T3 or thyromimetics [42]. It is
possible that in our model, LDL-R activity is
affected without changes in its mRNA levels as
seen by Kuo et al. [43]. They demonstrated that
changes in plasma-membrane fatty acyl composition
of the human hepatocarcinoma cell line HepG2 can
alter LDL uptake and metabolism without changing
gene expression. Probably, the increase of the
unsaturated fatty acid in the PMNs of the HT rats
could impinge on the LDL-C uptake by LDL-R
without modifying LDL-R mRNA levels. On the other
hand, Salter et al. [6] demonstrated that hepatocytes
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isolated from PTU-treated rats showed a
significant decrease in cholesterol esterification. This
finding agrees with the decreased content of EC in
PMNs that we found in HT rats.
The sterol regulatory element-binding
proteins (SREBPs) are transcriptional factors
regulated by cholesterol levels [44]. Shin et al [45]
showed that SREBP-2 promoter is activated by
the thyroid hormone. They postulated that changes
in the LDL-R mRNA expression in the mice liver
occur as a consequence of changes in SREBP-2 levels
caused by thyroid hormone alterations. However,
we did not find any change in the SREBP-2 mRNA
levels in the PMNs from PTU-induced HT rats.
As shown in Table 3, TG content increased
in PMNs isolated from the HT rats. The lipid
droplets or LBs are cytoplasmic inclusions present
within neutrophilic [46], eosinophilic [47] and
basophilic leukocytes [48], and many other cell types
[49]. Results obtained from neutrophils suggest that LBs
are composed largely of TG [50]. On the other hand,
LBs from PMNs become more prominent in
number and size when these leukocytes are engaged
in inflammatory responses [46]. In our experiments,
we observed that cellular TG concentration increases
in the PMNs of HT along with arise in the number
and size of LBs within those cells, as corroborated
by microscopic observation after Nile red staining
(Fig. 1).
Interestingly, TG pools within LBs do not function
as physiological stores of arachidonic acid for immediate
leucotriene generation [51]. The identification of TG lipase
and its activator CGI-58 within LBs opens the perspective
that this arachidonate could be used as a storage pool to
replenish (upon transfer) lipid body arachidonyl-
phospholipids. Thus, the activation of cytosolic
phospholipase A2 would provide arachidonate for local
eicosanoid biosynthesis from this endogenous pool
[52]. Although our results showed that the percentage
of arachidonic acid in hypothyroid PMNs decreased
significantly, it is possible that its levels increases
within the LBs. This would have important
physiological consequences [52], that should be further
investigated.
It is well known that DGAT (AcylCoA:diacylglycerol
acyltransferase) is a key enzyme in the pathway of
TG biosyntesis. In human tissues, the highest
DGAT-2 mRNA expression is observed in liver, mam-
mary gland, adipose tissue, testis, and peripheral
leukocytes; with lower expression in adrenal, thyroid, and
brain [53]. We did not find significant changes in the
DGAT-2 mRNA levels in PMNs of HT rats; however,
we can not discard posttranslational and/or
posttranslational effects of thyroid hormone alterations.
It is well known that DGAT activity is acutely regulated
by phosphorylation-dephosphorylation mechanisms [54],
and that the sn-3 position in TG contains mostly unsatu-
rated fatty acyl chains [55]. Other studies showed that
DGAT is more active with C18:1 and C18:2 both
acting as enzyme substrates [56]. PMNs isolated from
HT rats have a great increase of the C18:2 content.
Thus, such increase in the substrate concentration
could stimulate the enzymatic activity in our experimen-
tal model.
As stated previously, the main alteration found in
fatty acyl profile was a misbalance between saturated
and unsaturated fatty acyl chains, which lead to an
increased unsaturation index. Results obtained
from hypothyroid men showed a decrease in 16:0, 18:0
contents in plasma, whereas the levels of all the
monounsaturated fatty acids increased in the erythrocytes
[57]. Van Doormaal and collaborators [57] also
found an increased proportion of 18:2 n-6 contents,
facts that completely agree with our results. The
increased 18:2 n-6/20:4 n-6 ratio observed by us is
consistent with the alteration in the Δ6 desaturase activity
observed by those authors in hypothyroid men.
The modifications in the pattern of fatty
acid observed in PMN leukocytes from HT rats are similar
to those observed by others in the rat liver [58]. In PTU-
induced hypothyroidism, all the enzyme activities
involved in the biosynthesis of fatty acids (acetyl-CoA
carboxylase, fatty acid synthetase and microsomal
chain elongation and desaturation reactions) are
strongly reduced after three days of drug administration
[59].
Our results demonstrated that hypothyroidism causes
important changes in the lipid composition of PMN cells.
Lipid rafts are cholesterol and sphingolipid-enriched
domains of cellular membranes [60]. Interactions between
cholesterol, phospholipids and sphingolipids present in
rafts in specific amounts, create highly “lipid-ordered”
microdomains [61-63] which recruit signaling proteins and
act as staging areas for molecular signaling complexes.
Cholesterol bioavailability regulates membrane raft
composition and the trafficking of transient receptor
potential channel (TRPC) proteins. These proteins form
cation channels that can mediate agonist-induced
Ca2+ entry [64]. Many facets of PMNs activation
depend directly on Ca2+ entry into the cell [65], thus the
Cell Physiol Biochem 2012;29:713-724
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f P
en
ns
ylv
an
ia
16
5.
12
3.
34
.8
6 
- 9
/2
6/
20
13
 4
:3
7:
30
 P
M
722
References
1 Martín-Zurro A: Patología tiroidea.
Alteraciones del calcio; in Martín-Zurro
A (eds): Atención Primaria, España:
Elseiver, 2003, pp 1400-1456.
2 Dolphin PJ, Forsyth SJ: Nascent hepatic
lipoproteins in hypothyroid rats. J Lipid
Res 1983;24:541-551.
3 Diekman MJM, Anghelescu N, Endert E,
Bakker O, Wiersinga WM: Changes in
Plasma Low-Density Lipoprotein (LDL)-
and High-Density Lipoprotein
Cholesterol in Hypo- and Hyperthyroid
Patients Are Related to Changes in Free
Thyroxine, Not to Polymorphisms in
LDL Receptor or Cholesterol Ester
Transfer Protein Genes. J Clin
Endocrinol Metab 2000;85:1857-1862.
4 Hapon MB, Varas SM, Jahn GA, Giménez
MS: Effects of hypothyroidism on mam-
mary and liver lipid metabolism in virgin
and late-pregnant rats. J Lipid Res
2005;46:1320-1330.
5 Subudhi U, Das K, Paital B, Bhanja S,
Chainy GB: Supplementation of curcumin
and vitamin E enhances oxidative stress,
but restores hepatic histoarchitecture in
hypothyroid rats. Life Sci 2009;13:372-
379.
6 Salter AM, Hayashi R, Al-seeni M, Brown
NF, Bruce J, Sorensen O, Atkinson EA,
Middleton B, Bleackley RC, Brindley DN:
Effects of hypothyroidism and high-fat
feeding on mRNA concentrations for the
low-density-lipoprotein receptor and on
acyl-CoA:cholesterol acyltransferase
activities in rat liver Biochem J
1991;276:825-832.
7 Franco M, Castro G, Romero L, Regalado
JC, Medina A, Huesca-Gómez C, Ramírez
S, Montaño LF, Posadas-Romero C,
Pérez-Méndez O: Decreased activity of
lecithin:cholesterol acyltransferase and
hepatic lipase in chronic hypothyroid
rats: implications for reverse cholesterol
transport. Mol Cell Biochem
2003;246:51-56.
8 Popovic L, Oreskovic K, Zupancic B,
Petrunic M, Kunec-Vajic E: The relation
between plasma lipid levels and pseudo-
cholinesterase activity in hypothy-
roidism. Horm Metab Res 1998;30:137-
140.
9 Apostolopoulos JJ, Howlett GJ, Fidge N:
Effects of dietary cholesterol and hy-
pothyroidism on rat apolipoprotein
mRNA metabolism. J Lipid Res
1987;28:642-648.
10 Calder PC: n-3 fatty acids and mononu-
clear phagocyte function; in J.M. Kremer
(ed): Medicinal Fatty Acids. Birkhauser,
Basel, 1998, pp. 1-27.
11 Middleton J, Patterson AM, Gardner L,
Schmutz C, Ashton BA: Leukocyte ex-
travasation: chemokine transport and
presentation by the endothelium. Blood
2002;100:3853-3860.
12 Baggiolini M, Boulay F, Badwey JA,
Curnutte JT: Activation of neutrophil
leukocytes: chemoattractant receptors
and respiratory burst. FASEB J
1993;7:1004-1010.
13 Li S, Sun Y, Liang CP, Thorp EB, Han S,
Jehle AW, Saraswathi V, Pridgen B,
Kanter JE, Li R, Welch CL, Hasty AH,
Bornfeldt KE, Breslow JL, Tabas I, Tall
AR: Defective phagocytosis of apoptotic
cells by macrophages in atherosclerotic
lesions of ob/ob mice and reversal by a
fish oil diet. Circ Res 2009;20:1072-
1082.
14 Mutungi G, Torres-Gonzalez M, McGrane
MM, Volek JS, Fernandez ML:
Carbohydrate restriction and dietary
cholesterol modulate the expression of
HMG-CoA reductase and the LDL
receptor in mononuclear cells from adult
men. Lipids Health Dis 2007;28:6-34.
15 Lara LL, Rivera H, Perez-P C, Blanca I,
Bianco NE, De Sanctis JB: Low density
lipoprotein receptor expression and func-
tion in human polymorphonuclear
leukocytes. Clin Exp Immunol
1997;107:205-212.
16 Bonneau C, Couderc R, Roch-Arveiller
M, Giroud JP, Raichvarg D: Effects of
low-density lipoproteins on polymorpho-
nuclear leukocyte function in-vitro. J
Lipid Mediat Cell Signal 1997;10:203-
212.
17 Baillif RN, Kimbrough C: Studies on
leucocyte granules after staining with
sudan black B and May-Grünwald Giemsa.
J Lab Clin Med 1947;32:155-166.
18 Guo RF, Sun L, Gao H, Shi KX, Rittirsch
D, Sarma VJ, Zetoune FS, Ward PA: In
vivo regulation of neutrophil apoptosis
by C5a during sepsis. J Leukoc Biol
2006;80:1575-1583.
Coria/Carmona Viglianco/Marra/Gomez-Mejiba/Ramirez/Anzulovich/
Gimenez
cellular cholesterol deficiency could limit inflammatory
responses and regulate the immune cell activity. Recently,
non-genomic actions of thyroid hormones have been
described [66]. Some functions of PMNs, including
generation of reactive oxygen species (ROS), are
affected by hypothyroidism and are mediated by a
membrane-bound receptor for thyroid hormones [67, 68].
The lipid alterations observed in this work, may
affect the membrane composition and, consequently,
the no-genomic effects of thyroid hormones on PMN
cells.
In addition, previous evidence demonstrated that
changes in cellular cholesterol modify diverse
PMN functions. In neutrophils, the cholesterol
depletion increases lightly the adhesion efficiency to
P-selectin–coated beads, increase rolling velocity
while decrease the firm arrest to activated endothelium
[69]. In conclusion, we suggest that the PMNs
lipid alterations observed in HT rats could modify
the physiology of these cells, and therefore, the host
defense mechanism(s).
Acknowledgements
This work was partially supported by a
collaborative grant from Consejo Nacional de
Investigación Científica y Tecnológica (CONICET, PIP
6223) and Universidad Nacional de San Luis (Proyecto
8104). The authors thank to Mr Rosario del
Pilar Dominguez for his collaboration in the care
of animals.
Cell Physiol Biochem 2012;29:713-724
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f P
en
ns
ylv
an
ia
16
5.
12
3.
34
.8
6 
- 9
/2
6/
20
13
 4
:3
7:
30
 P
M
723
44 Horton JD, Goldstein JL, Brown MS:
SREBPs: activators of the complete
program of cholesterol and fatty acid
synthesis in the liver. J Clin Invest
2002;109:1125-1131.
45 Shin DJ, Osborne TF: Thyroid Hormone
Regulation and Cholesterol Metabolism
Are Connected through Sterol Regulatory
Element-binding Protein-2 (SREBP-2).
J Biol Chem 2003;278:34114-34118.
46 Weller PF, Ackerman SI, Nicholson-
Weller A, Dvorak AM: Cytoplasmic li-
pid bodies of human neutrophilic
leukocytes. Am J Pathol 1989;135:947-
959.
47 Weller PF, Dvorak AM: Arachidonic acid
incorporation by cytoplasmic lipid bodies
of human eosinophils. Blood
1985;65:269-1274.
48 Bandeira-Melo C, Phoofolo M, Weller
PF: Extranuclear lipid bodies, elicited by
CCR3-mediated signaling pathways, are
the sites of chemokine-enhanced
leukotriene C4 production in eosinophils
and basophils. J Biol Chem
2001;22:22779-22787.
49 Galli SJ, Dvorak AM, Peters SP,
Schulman ES, MacGlashan DW, Isomura
T, Pyne K, Harvey VS, Hammel I,
Lichtenstein LM, Dvorak HF: Lipid
Bodies. Widely distributed cytoplasmic
structures that represent preferential
nonmembrane repositories of exogenous
[3H] arachidonic acid incorporated by
mast cells, macrophages, and other cell
types; in Bailey JM (ed): Prostaglandins,
Leukotrienes, and Lipoxins, Plenum,
1985, pp 221-239.
50 Lutas EM, Zucker-Franklin D:
Formation of lipid inclusions in normal
human leukocytes. Blood 1977;49:309-
320.
51 Johnson MM, Vaughn B, Triggiani M,
Swan DD, Fonteh AN, Chilton FH: Role
of Arachidonyl Triglycerides within Li-
pid Bodies in Eicosanoid Formation by
Human Polymorphonuclear Cells. J
Respir Cell Mol Biol 1999;21:253-258.
52 Bozza PT, Magalhães KG, Weller PF:
Leukocyte lipid bodies - Biogenesis and
functions in inflammation. Biochim
Biophys Acta 2009;1791:540-551.
53 Coleman RA, Douglas PL: Enzymes of
triacylglycerol synthesis and their
regulation. Prog Lipid Res 2004;43:134-
176.
54 Coleman RA, Lewin TM, Muoio DM:
Physiological and nutritional regulation
of enzymes of triacylglycerol synthesis.
Ann Rev Nutr 2000;20:77-103.
55 Akesson B: Composition of rat liver
triacylglycerols and diacylglycerols. Eur
J Biochem 1969;9:463-477.
Hypothyroidism Alters Lipid Composition
19 Juaregui HO, Hayner NT, Driscoll JL,
Williams-Holland R, Lipsky MH, Galletti
PM: Trypan blue dye uptake and lactate
dehydrogenase in adult rat hepatocytes
freshly isolated cells, cell suspensions,
and primary monolayer cultures. In vitro
1981;17:1100-1110.
20 Finley PR, Schifman RB, Williams RJ,
Lichti DA: Cholesterol in high-density
lipoprotein: use of Mg2+/dextran sulfate
and its enzymatic measurement. Clin
Chem 1978;24:931-933.
21 Friedewald WT, Levy RI, Fredrickson DS:
Estimation of the concentration of low-
density lipoprotein cholesterol in plasma,
without use of the preparative
ultracentrifuge. Clin Chem 1972;18:499-
502.
22 Folch J, Less M, Sloane-Stanley GH: A
simple method for the isolation and pu-
rification of total lipid from animal tis-
sues. J Biol Chem 1968;226:497-509.
2 3 Malins DC, Mangold HK: Analysis of
complex lipid mixtures by thin layer chro-
matography and complementary meth-
ods. J Am Oil Chem Soc 1960;37:576-
582.
24 Fiske CH, Subbarow Y: Phosphorus
compounds of muscle and liver. Science
1929;18:381-382.
25 Zack B, Moss N, Boyle AS, Zlatkis A:
Reaction of certain unsaturated steroids
with acid iron reagent. Anal Chem
1954;26:776-777.
26 Ellis BA, Poynten A, Lowy AJ, Furler
SM, Chisholm DJ, Kraegen EW, Cooney
GJ: Long-chain acyl-CoA esters as
indicators of lipid metabolism and insulin
sensitivity in rat and human muscle. Am
J Physiol Endocrinol Metab
2000;279:554-560.
27 Sardesai VM, Manning JA: Determina-
tion of triglycerides in plasma and tis-
sues. Clin Chem 1968;14:156-161.
28 Marra CA, de Alaniz MJT: Influence of
Testosterone Administration on the Bio-
synthesis of Unsaturated Fatty Acids in
Male and Female Rats. Lipids
1989;24:1014-1019.
29 Balkin MS, Buchholtz M, Ortiz J, Green
AJ: Propylthiouracil (PTU)-induced
agranulocytosis treated with recombinant
human granulocyte colony-stimulating
factor (G-CSF). Thyroid 1993;3:305-
309.
30 Kariya K, Lee E, Hirouchi M: Relation-
ship between leukopenia and bone mar-
row myeloperoxidase in the rat treated
with propylthiouracil. Jpn J Pharmacol
1984;36:217-222.
31 Serebriakova OV, Govorin AV, Prosianik
VI, Baksheeva EV: Fatty acid
composition of the blood serum and
erythrocyte membrane lipids in patients
with hypothyroidism and left ventricular
diastolic dysfunction. Klin Med (Mosk)
2008;86:40-43.
3 2 van Doormaal JJ, Muskiet FA, Martini
IA, Doorenbos H: Changes in fatty acid
profiles of plasma, erythrocytes and
polymorphonuclear leukocytes in induced
hypothyroidism in man: indirect evidence
for altered delta 6 desaturase activity. Clin
Chim Acta 1986;15:299-313.
33 Bakan E, Yildirim A, Kurtul N, Polat MF,
Dursun H, Cayir K: Effects of type 2
diabetes mellitus on plasma fatty acid
composition and cholesterol content of
erythrocyte and leukocyte membranes.
Acta Diabetol 2006;43:109-113.
34 Berlin RD, Fera JP: Changes in membrane
microviscosity associated with
phagocytosis: effects of colchicine. Proc
Natl Acad Sci U S A 1977;74:1072-1076.
35 Gomes MG, Serakides R, Nunes VA, da
Silva CM, Carneiro RA, Ocarino NM:
Perfil Hematológico de Ratas Adultas
Hipotireóideas Castradas e Não Castradas.
Arq Bras Endocrinol Metanol
2004;48:294-298.
36 Perello M, Friedman T, Paez-Espinosa
V, Shen X, Stuart RC, Nillni EA: Thyroid
Hormones Selectively Regulate the
Posttranslational Processing of
Prothyrotropin-Releasing Hormone in
the Paraventricular Nucleus of the
Hypothalamus. Endocrinology
2006;147:2705-2716.
37 Duntas LH: Thyroid Disease and Lipids.
Thyroid 2002;12:287-293.
38 Byers SO, Rosenman RH, Friedman M,
Biggs MW: Rate of cholesterol synthesis
in hypo- and hyperthyroid rats. J Exp
Med 1952;96:513-516.
39 Dory L, Roheim PS: Rat plasma
lipoproteins and apolipoproteins in
experimental hypothyroidism. J Lipid
Res 1981;22:287-296.
40 Sample CE, Pendleton LC, Ness GC: Regu-
lation of 3-hydroxy-3-methylglutaryl
coenzyme A reductase levels by L-
triiodothyronine. Biochemistry
1987;26:727-731.
41 Cachefo A, Boucher P, Vidon C, Dusserre
E, Diraison F, Beylot M: Hepatic Lipo-
genesis and Cholesterol Synthesis in
Hyperthyroid Patients. J Clin Endocrinol
Metab 2001;86:5353-5357.
42 Ness GC, Lopez D, Chambers CM,
Newsome WP, Cornelius P, Long CA,
Harwood HJ Jr: Effects of L-
Triiodothyronine and the Thyromimetic
L-94901 on Serum Lipoprotein Levels
and Hepatic Low-Density Lipoprotein
Receptor, 3-Hydroxy-3-methylglutaryl
Coenzyme A Reductase, and Apo A-I Gene
Expression. Biochem Pharmacol
1998;56:121-129.
43 Kuo P, Weinfeld M, Loscalzo J: Effect
of membrane fatty acyl composition on
LDL metabolism in Hep G2 hepatocytes.
Biochemistry 1990;17:6626-6632.
Cell Physiol Biochem 2012;29:713-724
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f P
en
ns
ylv
an
ia
16
5.
12
3.
34
.8
6 
- 9
/2
6/
20
13
 4
:3
7:
30
 P
M
724
5 6 Dircks L, Sul HS: Acyltransferases of de
novo glycerophospholipid biosynthesis.
Prog Lipid Res 1999;38:461-479.
5 7 van Doormaal JJ, Muskiet FA, Martini
IA, Doorenbos H: Changes in fatty acid
profiles of plasma, erythrocytes and
polymorphonuclear leukocytes in induced
hypothyroidism in man: indirect evidence
for altered delta 6 desaturase activity. Clin
Chim Acta 1986;15:299-313.
58 Faas FH, Carter WJ: Fatty acid
desaturation and microsomal lipid fatty
acid composition in experimental
hypothyroidism. Biochem J
1982;207:29-35.
59 Landriscina C, Gnoni GV, Quagliariello
E: Effect of thyroid hormones on
microsomal fatty acid chain elongation
synthesis in rat liver. Eur J Biochem
1976;71:135-143.
60 Chini B, Parenti M: G-protein coupled
receptors in lipid rafts and caveolae: how,
when and why do they go there? J Mol
Endocrinol 2004;32:325-348.
61 Filippov A, Oradd G, Lindblom G: Lipid
lateral diffusion in ordered and disordered
phases in raft mixtures. Biophys J
2004;86:891-896.
62 Keller SL, Anderson TG, McConnell HM:
Miscibility critical pressures in
monolayers of ternary lipid mixtures.
Biophys J 2000;79:2033-2042.
63 Radhakrishnan A, McConnell H:
Condensed complexes in vesicles
containing cholesterol and phospholipids.
Proc Natl Acad Sci 2005;102:12662-
12666.
64 Kannan KB, Barlos D, Hauser CJ: Free
Cholesterol Alters Lipid Raft Structure
and Function Regulating Neutrophil Ca2+
Entry and Respiratory Burst:
Correlations with Calcium Channel Raft
Trafficking. J Immunol 2007;178:5253-
5261.
65 Hauser CJ, Fekete Z, Adams JM, Garced
M, Livingston DH, Deitch EA: PAF
mediated Ca2+ influx in human neutrophils
occurs via store operated mechanisms. J.
Leukocyte Biol 2001;69:63-68.
66 Axelband F, Dias J, Ferrão FM, Einicker-
Lamas M: Nongenomic signaling path-
ways triggered by thyroid hormones and
their metabolite 3-iodothyronamine on
the cardiovascular system. J Cell Physiol
2011;226:221-28.
67 Bergh JJ, Lin HY, Lansing L, Mohamed
SN, Davis FB, Mousa S, Davis PJ:
Integrin aVb3 contains a cell surface
receptor site for thyroid hormones that
is linked to activation of mitogen-acti-
vated protein kinase and induction of
angiogenesis. Endocrinology
2005;146:2864-2871.
68 De Vito P, Incerpi S, Pedersen JZ, Luly
P, Davis FB, Davis PJ: Thyroid Hormones
as Modulators of Immune Activities at
the Cellular Level. Thyroid
2011;21:879-890.
69 Oh H, Mohler ER, Tian A, Baumgart T,
Diamond SL: Membrane Cholesterol Is a
Biomechanical Regulator of Neutrophil
Adhesion. Arterioscler Thromb Vasc Biol
2009;29:1290-1297.
Coria/Carmona Viglianco/Marra/Gomez-Mejiba/Ramirez/Anzulovich/
Gimenez
Cell Physiol Biochem 2012;29:713-724
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
ity
 o
f P
en
ns
ylv
an
ia
16
5.
12
3.
34
.8
6 
- 9
/2
6/
20
13
 4
:3
7:
30
 P
M
